Welcome to LookChem.com Sign In|Join Free
  • or
4-Hydroxy-5-phenyl-1(2)H-pyrazole-3-carboxylic acid ethyl ester is a complex organic compound with the molecular formula C13H12N2O3. It features a pyrazole ring with a hydroxyl group at the 4-position, a phenyl group at the 5-position, and a carboxylic acid group at the 3-position, which is esterified with an ethyl group. This molecule is known for its potential applications in pharmaceuticals and as a chemical intermediate, particularly in the synthesis of various biologically active compounds. Its structure provides a foundation for further functionalization and modification, making it a valuable building block in organic synthesis.

34035-06-8

Post Buying Request

34035-06-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

34035-06-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 34035-06-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,0,3 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 34035-06:
(7*3)+(6*4)+(5*0)+(4*3)+(3*5)+(2*0)+(1*6)=78
78 % 10 = 8
So 34035-06-8 is a valid CAS Registry Number.

34035-06-8Relevant academic research and scientific papers

Discovery of novel hydroxy pyrazole based factor IXa inhibitor

Vijaykumar, Dange,Sprengeler, Paul A.,Shaghafi, Michael,Spencer, Jeffrey R.,Katz, Brad A.,Yu, Christine,Rai, Roopa,Young, Wendy B.,Schultz, Brian,Janc, James

, p. 2796 - 2799 (2006)

Synthesis and biological data of a novel selective and efficacious factor IXa inhibitor are described along with its crystal structure in factor VIIa.

HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS

-

, (2009/12/27)

The present invention relates to novel heterocyclic compounds of Formulae I-III: Formula I; [Chemical Formulas should be inserted here as they appears on abstract in.pdf form.] Formula II; Formula III as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 34035-06-8